4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0000905148-26-003351
Chief Financial Officer sold 7,783 shares at $2.95 ($22,942)
From the SEC's structured data for this filing
Trades in this filing
Gagnon Robert E. · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-23 | Sale : show line 1 in the form | −7,783 | $2.95 | $22,942 | 584,375 | D |
| Open-market sales · 7,783 sh · avg $2.95 · $22,942 | ||||||
Loading xslF345X06/form4.xml…